Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM).

Pharmaceutical Research
Asfar S AzmiFazlul H Sarkar

Abstract

Cancer chemoprevention is defined as the use of natural, synthetic, or biological agents to suppress, reverse or prevent the carcinogenic process from turning into aggressive cancer. Prostate apoptosis response-4 (Par-4) is a unique pro-apoptotic protein that selectively induces apoptosis in prostate cancer cells. However, its role in other malignancies has not been fully explored. This study tries to identify the functional significance of Par-4 in pancreatic cancer. Multiple molecular techniques such as Western blot analysis, trypan blue assay for cell viability, MTT assay for cell growth inhibition and Histone/DNA ELISA for apoptosis were used. Western blot analysis revealed that 3,3'-diindolylmethane (DIM) a chemopreventive agent, specifically its more bioavailable formulation, B-DIM, at low doses (20 micromol/L) induces Par-4, in L3.6pl and Colo-357 pancreatic cancer cells. At similar doses, DIM reduced cell viability and caused cell growth inhibition and apoptosis. Moreover, DIM pre-treatment sensitized the cells to cytotoxic action of chemotherapeutic drug gemcitabine through up-regulation of Par-4. The induction of Par-4 is indirectly related to increased sensitivity and cell death through apoptosis. To our knowledge th...Continue Reading

References

Dec 1, 1991·British Journal of Cancer·C M BartonR C Williamson
Mar 1, 1990·Baillière's Clinical Gastroenterology·D ShibataM Perucho
Jun 15, 1989·International Journal of Cancer. Journal International Du Cancer·K GrünewaldC R Bartram
Jan 1, 1994·The Journal of Cell Biology·J C Reed
Oct 9, 1999·The Journal of Biological Chemistry·A NalcaV M Rangnekar
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·J R Testa, A Bellacosa
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BrayD M Parkin
Jan 18, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Kip A WestPhillip A Dennis
Aug 20, 2003·World Journal of Surgery·Hans G BegerKarl-Heinz Link
Aug 30, 2003·American Journal of Surgery·Sarah M Cowgill, Peter Muscarella
Dec 4, 2003·Apoptosis : an International Journal on Programmed Cell Death·V M Rangnekar
Mar 31, 2004·Journal of the American College of Surgeons·Bridget N FahyRichard J Bold
Mar 31, 2004·Lancet·Donghui LiJames L Abbruzzese
May 12, 2005·Gastroenterology·Curtis J WrayAndrew M Lowy
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Mansoor M AhmedWilliam E Strodel

❮ Previous
Next ❯

Citations

May 5, 2010·Nature Reviews. Gastroenterology & Hepatology·Silvia D StanRandall E Brand
Jan 30, 2014·Marine Drugs·Valentin A Stonik, Sergey N Fedorov
Jan 1, 2014·Cancer Metastasis Reviews·Yiwei LiFazlul H Sarkar
Apr 24, 2014·Seminars in Cancer Biology·William T SenapedisYosef Landesman
May 4, 2012·Journal of Cellular Physiology·Nikhil HebbarVivek M Rangnekar
Oct 16, 2012·Expert Opinion on Therapeutic Targets·Rosalyn B Irby, Christina L B Kline
Jun 4, 2014·Expert Opinion on Therapeutic Targets·Wu QinanChen Bing
Nov 11, 2016·Cancer Biology & Therapy·Jeffrey Q Nguyen, Rosalyn B Irby
Jan 11, 2014·Journal of Medicinal Chemistry·Aaron MuthOtto Phanstiel
Jul 4, 2017·International Journal of Molecular Sciences·Man LiuThomas T Y Wang
Aug 29, 2016·Clinical & Experimental Metastasis·Reyaz Ur RasoolAnindya Goswami
Nov 11, 2018·BMC Pharmacology & Toxicology·Qiang LuoHongjing Guan
Aug 30, 2019·Current Pharmaceutical Design·Soraya SajadimajdRoja Rahimi
Apr 30, 2010·Expert Opinion on Therapeutic Targets·Asfar S AzmiRamzi M Mohammad
Nov 27, 2018·Current Drug Targets·Renata Virgínia Cavalcanti SantosMichelly Cristiny Pereira
May 10, 2020·Health Physics·Evagelia C LaiakisAlbert J Fornace

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis